Both semaglutide and tirzepatide are GLP-1 medications available at Transformare Bellezza — but they work differently and deliver different levels of results.
Semaglutide (Ozempic®, Wegovy®) is a GLP-1 receptor agonist. It activates a single hormone pathway to reduce appetite, slow digestion, and stabilize blood sugar. Clinical trials show an average of 14–17% total body weight loss over 68 weeks — making it a highly effective, well-documented option for clients in East Hanover and across Morris County NJ looking for medically supervised weight loss.
Tirzepatide (Mounjaro®, Zepbound®) is a dual GIP/GLP-1 receptor agonist — it activates two hormone receptors simultaneously, producing stronger appetite suppression and a more powerful metabolic effect. Clinical trials showed 20–22.5% average total body weight loss, making tirzepatide currently the most effective non-surgical weight loss medication available.
Which is right for you? That depends on your health history, starting weight, and goals. Many clients start conservatively with semaglutide and transition to tirzepatide for accelerated results. Our licensed team will make a personalized recommendation at your consultation — never a one-size-fits-all prescription.